Adrian Quartel, MD: Next Steps for Evaluating KP1077 in Idiopathic Hypersomnia
In an interview Adrian Quartel, MD, discusses the next steps for evaluating KP1077 in idiopathic hypersomnia after the phase 2 study.
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
The phase 2 findings set up the foundation to design a phase 3 trial evaluating KP1077 for idiopathic hypersomnia.
David Gozal, MD: Heterogeneity Poses Challenges to Diagnose Pediatric OSA
Gozal told HCPLive about the issue of the classic approach when diagnosing children with OSA.
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
Bourjeily told HCPLive at SLEEP 2024 that sleep issues, such as insomnia and restless legs syndrome, are the most common during the first and third trimester of pregnancy.
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
The first line treatment for restless legs syndrome—dopamine agonists—may be making a patient’s condition worse in the long-term, Winkelman told HCPLive at SLEEP 2024.
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
At SLEEP 2024, Kolla shared tips to help his fellow practitioners for improving patient outcomes when dealing with patients with both sleep issues and psychiatric illnesses.
Jennifer Martin, PhD: Boosting CPAP Adherence in Women with Sleep Apnea
Martin spoke about the barriers standing in the way of CPAP adherence in women with sleep apnea at SLEEP 2024.
Effectiveness of TruCBN for Improving Sleep, with Vaughn Hartung
At SLEEP 2024, Hartung discussed FloraWorks’ study finding patients on CBN had greater improvements in sleep quality than melatonin, but the difference was not significant.
M. Safwan Badr, MD: What are the Novel Treatments for Central Sleep Apnea?
At SLEEP 2024, Badr presented on novel treatments for central sleep apnea like phrenic nerve stimulation.
Treating Sleep-Related Anxiety with Michael Grandner, PhD
Grandner highlights the importance of focusing on insomnia treatment for sleep-related anxiety—not anxiety treatment.
Judite Blanc, PhD: VR on Maternal Stress, Sleep Reduction in Women of Color
During SLEEP 2024, Judite Blanc, PhD, discussed her team’s ongoing study assessing whether an education VR program improves maternal stress and sleep among women of color.
Josiane Broussard, PhD: Meal Timings Impact on Sleep
At SLEEP 2024, Broussard told HCPLive about how eating time restriction can serve as another as another dietary tool for people who are unsuccessful with other strategies.
Josiane Broussard, PhD: Meal Timings Effect on Cardiometabolic Health, Sleep
Broussard discussed the importance of eating during the day at SLEEP 2024.
Allison Brager, PhD: Exercise’s Impact on Cardiovascular Health, Circadian Clock
In an interview at SLEEP 2024, Brager talked about the benefits of exercise on cardiovascular health and sleep.
Sairam Parthasarathy, MD: Researching Sleep Disturbances’ Impact on Immunity
Parthasarathy discussed next steps for research on the relationship between sleep disturbances and immunity in an interview with HCPLive at SLEEP 2024.
Sairam Parthasarathy, MD: Sleep Issues Affect COVID-19, Vary by Sex
Parthasarathy told HCPLive women have a weaker immune response to COVID-19 than men.
Sairam Parthasarathy, MD: How Sleep Disturbances Impact Immune Function
In an interview with HCPLive, Parthasarathy discussed the relationship between sleep disturbances and immune function.
Lourdes DelRosso, MD, PhD: Goals, Insights from the “Count on Sleep” OSA Project
In an interview with HCPLive, DelRosso spoke about the 1-year plans of the "Count on Sleep" OSA project.
Amee Revana, DO, FAASM: Pitolisant Reduces Sleepiness in Prader-Willi Syndrome
At SLEEP 2024, Revana told HCPLive her thoughts on the potential of pitolisant to address excessive daytime sleepiness in Prader-Willi syndrome compared to treating narcolepsy.
Postmenopausal Women with Vasomotor Symptoms Have Frequent Sleep Issues
Analysis of the OASIS trial shows, on average, women post-menopause with vasomotor symptoms experience at least moderate rates of sleep disturbance.
COPD with Greater Mortality Risk Linked to Worse Sleep Quality
A study presented as a late breaker at SLEEP 2024 found patients with COPD who have a greater mortality risk have a worse sleep quality.
Pharyngeal Opening Pressure More Common in Black Patients with OSA
A cohort analysis suggests upper airway collapsibility prevalence may correlate closely to race in patients with OSA.
Patients More Likely to Adhere to Fixed CPAP Versus Automatic Titration Option
New study data show patients with OSA may use a fixed CPAP device for a longer daily duration than those with an automatic option.
No Link Found Between Nightmare Severity and Next-Day Suicidal Ideation Severity
Presented at SLEEP 2024 as a late-breaker, a study found a positive relationship exists between suicide severity on any day and next-day suicide severity.
Sleep Disorders not Linked to Worse QoL in Veterans with PTSD
New data presented at SLEEP 2024 show sleep disorders including insomnia are only linked to worse quality of life when veterans do not also have PTSD.
Medicinal Cannabis Shows Promise for Managing Sleep in Children with ASD
A study presented at SLEEP 2024 found medicinal cannabis shows promise for improving sleep onset latency, quality, and duration in children with ASD.
Tirzepatide Significantly Reduces Weight in Patients with OSA
New analysis from SURMOUNT-1 support the use of GLP-1/GIP agonist tirzepatide to reduce weight in patients with OSA and obesity/overweight.
Melatonin Increased Hospitalized Patients' Sleep Quality by 32%
A study presented at SLEEP 2024 found melatonin increased sleep latency and overall sleep quality and decreased awakenings.
OSA Mandibular Advancement Devices Optimized by Jaw Movement Monitoring
A late-breaking abstract from SLEEP 2024 shows the effect of mandibular devices on respiratory effort, and its overall impact on OSA.
Novel Mouthguard Device Significantly Reduces Nightly Sleep Apnea Events
An alternative device to CPAP shows clinical benefit and long-term patient adherence in new SLEEP 2024 trial data.
